Top compounds associated with response to RP11-1012A1.4


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC 0.017 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA B02 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV